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doi:10.1016/j.ejvs.2009.09.002Abstract Objectives: This study evaluated the prognostic value of asymptomatic low ankle-
brachial index (ABI) to predict perioperative myocardial damage, incremental to conventional
cardiac risk factors imbedded in cardiac risk indices (Revised Cardiac index and Adapted Lee
index).
Materials and methods: Preoperative ABI measurements were performed in 627 consecutive
vascular surgery patients (carotid artery or abdominal aortic aneurysm repair). An ABI< 0.90
was considered abnormal. Patients with ABI> 1.40 or (a history of) intermittent claudication were
excluded. Serial troponin-T measurementswereperformed routinelybeforeandafter surgery. The
main study endpoint was perioperative myocardial damage, the composite of myocardial
ischaemia and infarction. Multivariate regression analyses, adjusted for conventional risk factors,
evaluated the relation between asymptomatic low ABI and perioperative myocardial damage.
Results: In total, 148 (23%) patients had asymptomatic low ABI (mean 0.73, standard
deviation 0.13). Perioperative myocardial damage was recorded in 107 (18%) patients. Multivar-
iate regressionanalysesdemonstrated thatasymptomatic lowABIwasassociatedwithan increased
risk of perioperative myocardial damage (odds ratio (OR): 2.4, 95% CI: 1.4e4.2)
Conclusions: This study demonstrated that asymptomatic low ABI has a prognostic value to
predict perioperative myocardial damage in vascular surgery patients, incremental to risk factors
imbedded in conventional cardiac risk indices.
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he Netherlands. Tel.: þ31 10
smusmc.nl (D. Poldermans).
ty for Vascular Surgery. PublisheCardiac complications constitute the leading cause of post
operative morbidity or mortality, with a prevalence repor-
ted to range from 2.2% to 19.0% in vascular surgery
patients.1 The high incidence of perioperative cardiacd by Elsevier Ltd. All rights reserved.
Peripheral Arterial Disease and Myocardial Damage 63complications reflects the high prevalence of underlying
ischaemic heart disease.2,3 Adequate preoperative evalua-
tion is inevitable in vascular surgery patients to (1) identify
patients at increased cardiac risk, (2) initiate risk-reduction
therapy and (3) select optimal surgical and anaesthesia
techniques.
In conventional preoperative cardiac risk indices
(Revised Cardiac Risk index and Adapted Lee index), age,
heart failure, ischaemic heart disease, cerebrovascular
disease, renal dysfunction, diabetes mellitus and high-risk
surgery have been identified as independent predictors of
perioperative cardiovascular events.4,5
Peripheral arterial disease (PAD) is associated with an
increased risk of cardiovascular mortality and morbidity.
The ankle-brachial index (ABI) is a simple non-invasive test
to screen patients with suspected PAD.6,7 In the non-
surgical setting, a resting low ABI (ABI< 0.90) has been
associated with a two- to fourfold increased risk of
cardiovascular mortality or severe cardiovascular events
compared with normal ABI.7e10 Low ABI has demonstrated
to improve risk prediction for cardiovascular mortality and
major non-fatal myocardial infarction (non-surgical
setting), even beyond risk prediction properties using
cardiac risk scores.9,11 However, the predictive value of
asymptomatic low ABI for perioperative myocardial damage
has not been studied yet. The current study evaluated ifFigure 1 Overview of the selected patientasymptomatic low ABI has a predictive value for perioper-
ative myocardial damage, independent from conventional
risk factors imbedded in conventional cardiac risk indices.
Material and Methods
Study population
The original study population consisted of 1113 consecutive
patients undergoing vascular surgery during the period
2002e2009. The study was performed at the Erasmus
Medical Center in Rotterdam, a tertiary hospital in the
Netherlands. After exclusion of (1) lower-extremity arterial
or abdominal aortic stenosis repair patients, (2) patients
with (a history of or current) intermittent claudication
assessed with the Edinburgh questionnaire12 and (3)
patients with asymptomatic ABI> 1.40;13 a total 627
patients were included (Fig. 1). The study was approved by
the hospital’s ethics committee and performed with the
informed consent of all patients.
Baseline characteristics
Prior to surgery, a detailed history was obtained from every
patient. Clinical data included age, sex, ischaemic heartpopulation. ABIZ ankle-brachial index.
64 W.-J. Flu et al.disease (defined as a history of myocardial infarction,
coronary revascularisation or the presence of pathologic
Q-waves on preoperative electrocardiogram), cerebrovas-
cular disease (defined as a history of ischaemic or hae-
morrhagic stroke), renal dysfunction (serum creatinine
>2.0 mg dle1), diabetes mellitus (fasting blood gluco-
se 6.1 mmol le1 or requirement of anti-diabetic medica-
tion), hypertension (blood pressure 140/90 mmHg in non-
diabetics and 130/80 mmHg in diabetics or requirement
of antihypertensive medication), hypercholesterolemia
(history of hypercholesterolemia or low-density lipoprotein
(LDL) cholesterol >3.5 mmol le1), chronic obstructive
pulmonary disease (history of chronic obstructive pulmo-
nary disease or according to the Global Initiative on
Obstructive Lung Diseases classification) and smoking
status. The use of the prescription medications was
captured and included beta-blockers, statins, angiotensin-
converting enzyme inhibitors, aspirin and oral anticoagu-
lants. Preoperatively, transthoracic echocardiography was
performed in all patients using a hand-held Acuson Cypress
Ultrasound System (7V3c transducer) manufacturers
address 1220 Charleston Road, Mountain View, CA 94043.
Standard parasternal and apical two- and four-chamber
views were obtained during rest with the patient in the left
lateral decubitus position, as recommended.14 Left
ventricular end-systolic and end-diastolic volumes were
determined and left ventricular ejection fraction was
calculated using the biplane Simpson’s technique.15
Systolic left ventricular dysfunction was defined as left
ventricular ejection fraction <40%.
Ankle-brachial index
The ABI at rest was measured in each patient by trained
technicians, using a Doppler ultrasonic instrument with an
8-MHz vascular probe (Imexdop CTþ Vascular Doppler;
Nicolet Vascular, Madison, WI, USA). The ABI in the right
and left leg was calculated by dividing the right and the left
ankle pressures by the brachial pressure. The higher of the
two brachial blood pressures was used if a discrepancy in
systolic blood pressure was present. Further, the higher of
the dorsalis pedis and posterior tibial artery pressures was
used if a discrepancy in systolic blood pressure between the
two arteries was measured.16 Asymptomatic low ABI was
defined as an ABI< 0.90 with an inter- and intra-observer
agreement of 97% and 98%, as shown previously.17
Study outcomes
The main study endpoints were perioperative myocardial
damage (defined as non-fatal myocardial ischaemia or
infarction up to 30 days after surgery) and long-term
mortality. Serial electrocardiograms and troponin-T
measurements were obtained from all patients prior to
surgery, postoperatively on days 1, 3 and 7 and before
discharge. Myocardial ischaemia was present in patients
with normal preoperative and elevated (>0.03 ng mle1)
troponin-T levels postoperatively.18 Elevated troponin-T
levels in combination with electrocardiographic changes
(new-onset STeT changes and pathological Q-waves) or
symptoms of angina pectoris defined myocardialinfarction.19 Patients with elevated troponin-T levels prior
to surgery were not included in the study. Long-term
mortality was assessed by approaching the municipal civil
registries. Median follow-up was 2 years (interquartile
range (IQR) 1e3).
Statistical analysis
Dichotomous data are described as numbers and percent-
ages. Continuous variables are described as mean -
 standard deviation (SD). Continuous data were compared
using ANOVA and categorical data were compared using
a chi-square test. Cox regression analyses were performed
to evaluate the relationship between asymptomatic low ABI
and the study endpoint, perioperative myocardial damage
and long-term mortality. Cumulative long-term survival was
determined using the KaplaneMeier method. Multivariate
regression analyses were adjusted for sex, hypercholes-
terolemia, hypertension, chronic obstructive pulmonary
disease, current smoking and risk factors imbedded in
conventional cardiac risk indices (age, ischaemic heart
disease, symptomatic heart failure, cerebrovascular
disease, renal dysfunction, diabetes mellitus and high-risk
surgery).We report both the crude and the adjusted odds
ratio (OR) and hazard ratios (HRs) with their 95% confidence
intervals (95% CIs). For all tests, a P-value <0.05 (two-
sided) was considered significant. All analyses were per-
formed using SPSS version 15.0 statistical software (SPSS
Inc., Chicago, IL, USA).
Results
Prevalence of PAD and baseline characteristics
The initial study population consisted of 690 patients. In
total, 54 patients with (a history of) intermittent claudi-
cation and nine patients with an asymptomatic ABI> 1.40
were excluded from the analyses. Therefore, 627 patients,
without (a history of) intermittent claudication, undergoing
carotid artery stenosis (NZ 241) or abdominal aortic
aneurysm (NZ 386) repair were included in the study. In
total, 148 (23%) patients had asymptomatic low ABI (mean
0.73, SD 0.13). The distribution of asymptomatic low ABI
values is demonstrated in Fig. 2. In addition, baseline
characteristics stratified to ABI are shown in Table 1. The
majority of patients were males (82%) and the mean age
was 70 (SD 8.6) years. Asymptomatic low ABI was associ-
ated with ischaemic heart disease, renal dysfunction,
smoking and a left ventricular ejection fraction <40%.
Perioperative myocardial damage
The study endpoint, perioperative myocardial damage, was
reached in 107 (17%) patients, as shown in Table 2. Of these
patients, 76 (71%) had myocardial ischaemia and 31 (29%)
had myocardial infarction. Symptoms of angina pectoris
were reported in only six (6%) patients. As demonstrated in
Table 2, the prevalence of perioperative myocardial
damage was the highest in patients undergoing AAA repair
of open surgery. In addition, 32% (47/148) of patients with
Figure 2 Distribution of ankle-brachial index <0.90 in
asymptomatic patients. ABIZ ankle-brachial index.
Table 1 Baseline characteristics of the study population.
Baseline characteristics ABI 0.9
[NZ 479]
ABI< 0.9
[NZ 148]
P-value
Demographics
Age (standard
deviation)
70 (9) 69 (8) 0.91
Body mass
index (standard
deviation)
26 (3) 26 (4) 0.94
Male (%) 378 (79) 130 (88) 0.02
Medical history (%)
Ischaemic heart
disease (%)
183 (37) 71 (48) 0.01
Clinical heart
failure (%)
48 (10) 19 (13) 0.30
Cerebrovascular
disease (%)
231 (48) 69 (47) 0.73
Renal dysfunction (%) 67 (14) 33 (23) 0.03
Diabetes mellitus (%) 117 (24) 38 (29) 0.57
Hypertension (%) 278 (63) 82 (65) 0.61
Hypercholesterolemia (%) 287 (61) 67 (62) 0.78
Chronic obstructive
pulmonary disease (%)
155 (32) 56 (38) 0.22
Smoking, current (%) 162 (34) 69 (46) 0.01
Echocardiography
Left ventricular
ejection fraction
< 40% (%)
79 (17) 50 (34) <0.01
Medication
Beta-blockers (%) 368 (77) 121 (82) 0.21
Statins (%) 357 (75) 99 (67) 0.08
Angiotensin-converting
enzyme inhibitors (%)
120 (27) 40 (32) 0.37
Aspirin (%) 287 (60) 81 (55) 0.26
Oral anticoagulants (%) 57 (12) 26 (18) 0.08
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damage compared with 13% (60/479) of patients with
normal ABI.
Multivariate analyses showed that risk factors imbedded
in the Revised Cardiac index and Adapted Lee index
(combined risk factors) were predictive for perioperative
myocardial damage, as shown in Table 3A, Model 1. When
including ABI in the model (Table 3A, Model 2þ 3),
asymptomatic low ABI was independently associated with
an increased risk of perioperative myocardial damage with
an OR of 2.4 (95% CI: 1.4e4.2). The risk for developing
myocardial damage was higher in patients with asymp-
tomatic ABI< 0.70 (OR: 2.6, 95% CI: 1.4e5.1) compared
with patients with asymptomatic ABI 0.70e0.89 (OR: 2.3,
95% CI: 1.3e4.4). In addition, patients with low ABI and (a
history of) intermittent claudication had the highest risk for
developing perioperative myocardial damage (OR: 2.8, 95%
CI: 1.2e6.4).
Multivariate sub-analyses performed in patients under-
going AAA repair, and patients undergoing carotid repair
separately, demonstrated that asymptomatic low ABI was
associated with an increased risk for myocardial damage in
both groups with ORs of 1.9 (95% CI: 1.1e3.6) and 5.3 (95%
CI: 2.4e19.8), respectively.
Long-term mortality
In total, 111 (18%) patients died during follow-up (Table 2)
and the prevalence of long-term mortality was the highest
in patients undergoing AAA repair. Of the patients who
died, 36% (40/111) had perioperative myocardial damage
and 39% (43/111) patients had asymptomatic low ABI.
Cumulative 6-year survival (log rank p< 0.01) is shown in
Fig. 3. Survival rates in patients with normal ABI and
asymptomatic low ABI were (1) 87 2% and 72 5% during
a 2-year follow-up, (2) 76 3% and 59 6% during a 4-year
follow-up and (3) 60 6% and 48 9% during a 6-year
follow-up, respectively.
Multivariate analyses showed that the combined risk
factors were predictive for long-term mortality, as shown in
Table 3B, Model 1. When including ABI in the model (Table
3B, Model 2þ 3), asymptomatic low ABI was independentlyassociated with an increased risk of long-term mortality
with a HR of 1.9 (95% CI: 1.2e2.8). The risk of long-term
mortality was higher in patients with asymptomatic
ABI< 0.70 (HR: 2.4, 95% CI: 1.5e3.8) compared with
patients with asymptomatic ABI 0.70e0.89 (HR: 1.6, 95% CI:
1.1e2.6). In addition, patients with low ABI and (a history
of) intermittent claudication had the highest risk of long-
term mortality (HR: 3.0, 95% CI: 1.2e3.4).
Multivariate sub-analyses performed in patients under-
going AAA repair, and patients undergoing carotid repair
separately, demonstrated that asymptomatic low ABI was
associated with an increased risk for long-term mortality in
both groups with HRs of 1.8 (95% CI: 1.2e3.0) and 2.3 (95%
CI: 1.7e7.9), respectively.
Discussion
The current study demonstrated that asymptomatic low ABI
was present in around one out of four patients undergoing
carotid artery stenosis or abdominal aortic aneurysm
repair. To our knowledge, this study is the first to
Table 2 Ankle-brachial index and post operative outcome.
Follow-up All NZ 627 ABI> 0.9 NZ 479 ABI< 0.9 NZ 148 P-value
Perioperative myocardial damage
All procedures 107/627 (17) 60/479 (13) 47/148 (32) <0.01
AAA open procedures 67/208 (32) 42/148 (28) 25/60 (42) <0.01
endovascular procedures 20/178 (11) 9/138 (6) 11/40 (28) <0.01
Carotid open procedures 16/156 (10) 8/125 (7) 8/31 (26) <0.01
endovascular procedures 4/85 (5) 1/68 (2) 3/17 (18) <0.01
Long-term mortality
All procedures 111/627 (18) 74/479 (15) 43/148 (27) <0.01
AAA open procedures 60/208 (29) 36/148 (24) 24/60 (40) <0.01
endovascular procedures 33/178 (19) 23/138 (17) 10/40 (25) <0.01
Carotid open procedures 13/156 (8) 10/125 (8) 6/31 (19) <0.01
endovascular procedures 5/85 (6) 2/68 (3) 3/17 (18) <0.01
66 W.-J. Flu et al.demonstrate that asymptomatic low ABI has prognostic
value to predict perioperative myocardial damage in
vascular surgery patients, incremental to risk factors
imbedded in conventional cardiac risk indices.
Ischaemic heart disease, cerebrovascular disease and
PAD result from atherosclerotic arterial disease. Athero-
sclerosis is a systemic inflammatory disease of the vascu-
lature and a response to injury, lipid peroxidation and
inflammation. The process of atherosclerosis is known to
affect multiple sections of the arterial tree simulta-
neously.20 Large international registries, such as the REACH
registry, have shown a high prevalence of multiple-affected
vascular beds in patients with PAD (around 20%) indicating
that these patients often have concomitant ischaemic heart
or cerebrovascular disease.21 The ABI is a non-invasive and
reliable indicator for the atherosclerotic status of the lowerTable 3A Multivariate association between ankle-brachial inde
Characteristics Model 1a
Myocardial damage Odds ratio [95% CI]
Combined Risk Factors
Age (>70 years) 1.6 2.1e5.2
Symptomatic heart failure 3.2 1.7e5.5
Ischaemic heart disease 2.4 1.3e4.6
Cerebrovascular disease 1.4 1.9e6.1
Renal dysfunction 1.7 1.8e7.7
Diabetes mellitus 1.2 1.1e3.0
High-risk surgery 7.3 3.6e14.6
ABI
0.90 e e
<0.90 asymptomatic e e
<0.90 intermittent claudication e e
95% CIZ 95% confidence interval, ABIZ ankle-brachial index.
a Model 1: Predictive value of Combined Risk Factors derived fro
adjusted for: gender, hypercholesterolemia, hypertension, chronic ob
b Model 2: Predictive value of low ABI: multivariate analyses adjus
fraction<40%, hypercholesterolemia, hypertension, chronic obstruct
c Model 3: Predictive value of low ABI: multivariate analyses adjust
aspirin, oral anticoagulants and angiotensin-converting enzym inhibitleg vasculature.6,7 Multiple studies have demonstrated that
the majority of patients with PAD, defined as ABI< 0.90,
are asymptomatic.10,22,23 Patients with asymptomatic PAD
have an increased risk for cardiovascular disease, equal to
patients with intermittent claudication.8 The high preva-
lence of asymptomatic PAD suggests that ABI should be
systematically measured in high-risk hospitalised patients
to ensure that appropriate secondary prevention pro-
grammes are initiated.24 In our patient population, three
out of four patients with low ABI did not have (a history of)
intermittent claudication.
The current study is the first to demonstrate that, after
adjusting for risk factors imbedded in conventional cardiac
risk indices, asymptomatic low ABI was associated with an
increased risk of perioperative myocardial damage in
vascular surgery patients. The prevalence of myocardialx and perioperative myocardial damage.
Model 2b Model 3c
Odds ratio [95% CI] Odds ratio [95% CI]
1.4 1.9e5.0 1.4 1.9e4.8
3.1 1.6e5.8 3.1 1.6e6.0
2.6 1.5e5.2 2.7 1.7e5.3
1.6 1.9e6.7 1.7 2.0e6.9
1.5 1.6e7.3 1.5 1.6e7.2
1.3 1.2e3.3 1.3 1.2e3.4
8.4 3.8e18.4 9.2 4.0e21.0
e e
2.4 1.4e4.1 2.4 1.4e4.2
2.7 1.2e6.0 2.8 1.2e6.4
m the RCR and Adapted Lee Risk Indices: multivariate analysis
structive pulmonary disease and current smoking.
ted for Combined Risk Factors, gender, left ventricular ejection
ive pulmonary disease and current smoking.
ed as in model 2 and for medication use (beta-blockers, statines,
ors).
Figure 3 Cumulative long-term survival. ABIZ ankle-brachial
index.
Peripheral Arterial Disease and Myocardial Damage 67ischaemia has been evaluated in the non-surgical setting
that focussed on patients with symptomatic PAD and
without clinical ischaemic heart disease. In a study con-
ducted by Raby et al., the prevalence of myocardial
ischaemia detected with Holter monitoring was around 18%
and was demonstrated to be an independent predictor of 2-
year prognosis.25
The ABI collaboration group demonstrated that low ABI
has the potential to improve risk prediction for major non-
fatal myocardial infarction, beyond the Framingham RiskTable 3B Multivariate association between ankle-brachial inde
Characteristics Model 1a
Long-term mortality Hazard ratio [95% CI]
Combined risk factors
Age (>70 years) 3.2 1.3e4.2
Symptomatic heart failure 2.6 1.6e3.4
Ischaemic heart disease 2.0 1.2e4.9
Cerebrovascular disease 1.2 1.1e3.2
Renal dysfunction 2.3 1.6e4.0
Diabetes mellitus,
insulin dependent
1.2 1.2e3.5
High-risk surgery 2.9 1.6e3.4
ABI
0.90 e e
<0.90 asymptomatic e e
<0.90 intermittent claudication e e
95% CIZ 95% confidence interval, ABIZ ankle-brachial index.
a Model 1: Predictive value of Combined Risk Factors derived fro
adjusted for: gender, hypercholesterolemia, hypertension, chronic ob
b Model 2: Predictive value of low ABI: multivariate analyses adjus
fraction <40%, hypercholesterolemia, hypertension, chronic obstruct
c Model 3: Predictive value of low ABI: multivariate analyses adjust
aspirin, oral anticoagulants and angiotensin-converting enzym inhibitScore.11 Recently, Mostaza et al. evaluated silent myocar-
dial ischaemia, detected with exercise stress tests, in 85
patients with asymptomatic low ABI. Although the sample
size in this study was limited, the authors found that
a positive exercise test was present in 16% of patients with
asymptomatic low ABI, compared with 3.5% in control
patients.26 As the authors themselves state, the real prev-
alence of ischaemic heart disease in these patients remains
unknown, because no additional tests were performed in
patients with a positive exercise test. To our knowledge,
the impact of asymptomatic low ABI on perioperative
myocardial damage in vascular surgery patients has not
been studied yet. The current study demonstrated that the
risk of patients with asymptomatic low ABI to develop
perioperative myocardial damage was more than twice as
high compared with patients with normal ABI. In line with
previous studies, endovascular surgery was associated with
a reduced incidence of perioperative myocardial damage,
possibly explained by reduced myocardial stress during
endovascular procedures.27,28
Perioperative myocardial damage is most often silent
and the great majority of these patients (95%) remain
untreated, which might contribute to an increased risk of
long-term cardiovascular mortality.25,27,29e31
Multiple studies have demonstrated that low ABI has the
potential to improve prediction of long-term mortality over
and above conventional risk factors.9,11 In line with these
studies, we found that after adjusting for conventional risk
factors, imbedded in conventional cardiac risk indices,
asymptomatic low ABI was associated with increased risk of
long-term mortality after vascular surgery.
Our results indicate that preoperative counselling of
vascular surgery patients undergoing carotid stenosis or
aortic aneurysm repair should include systematic screeningx and long-term mortality.
Model 2b Model 3c
Hazard ratio [95% CI] Hazard ratio [95% CI]
3.0 1.2e4.3 3.0 1.2e4.2
2.5 1.6e4.0 2.3 1.4e3.7
1.8 1.1e5.2 1.7 1.1e5.4
1.3 1.2e3.8 1.3 1.1e3.9
1.9 1.1e3.7 1.9 1.1e3.6
1.7 1.4e3.7 1.7 1.4e3.8
2.0 1.2e3.8 1.9 1.1e3.7
e e
2.0 1.3e3.0 1.9 1.2e2.8
3.1 1.2e3.6 3.0 1.2e3.4
m the RCR and Adapted Lee Risk Indices: multivariate analysis
structive pulmonary disease and current smoking.
ted for Combined Risk Factors, gender, left ventricular ejection
ive pulmonary disease and current smoking.
ed as in model 2 and for medication use (beta-blockers, statines,
ors).
68 W.-J. Flu et al.for asymptomatic lower-extremity PAD by measuring the ABI.
A recent study conducted by Hoeks et al. has observed a care
gap between guideline recommendations and clinical prac-
tice in PAD patients.32 Standard screening for asymptomatic
PAD could reduce this observed care gap by initiating rec-
ommended medical treatment with (1) statins, (2) anti-
platelet therapy to reduce the risk of adverse cardiovascular
ischaemic events and (3) angiotensin-converting enzyme
inhibition, which may be considered for cardiovascular risk
reduction.33 The presence of asymptomatic lower-extremity
PAD creates the need for optimal lifestyle modification and
screening for additional risk factors. Our results indicate that
asymptomatic lower-extremity PAD is associated with an
increased risk for systolic left ventricular dysfunction and
ischaemic heart disease. Standard cardiac evaluation during
preoperative counselling should therefore be considered in
asymptomatic lower-extremity PAD patients. Asymptomatic
systolic left ventricular dysfunction with an ejection fraction
<40% should be treated with an angiotensin-converting
enzyme inhibitor or, in case of intolerance, an angiotensin-
receptor blocker. In patients with a history of ischaemic
heart disease, beta-blockers treatment should be initiated as
well.34 Patients with asymptomatic lower-extremity PAD are
at increased risk for perioperative myocardial damage. Per-
ioperative monitoring with cardiac biomarkers, such as
troponin-T, could be justified since the majority of peri-
operative myocardial damage is silent and patients therefore
remain untreated. Available evidence suggests that beta-
blockers reduce perioperative ischaemia and the latest
American College of Cardiology/American Heart Association
(ACC/AHA) guidelines on perioperative care provide a (Class
IIa, Level of evidence B) recommendation to initiate beta-
blocker treatment in patients with one or more cardiovas-
cular risk factors.35
Potential limitations of these data merit consideration.
First, the study population consisted of patients referred to
a tertiary referral center and may not fully represent
a general population scheduled for elective vascular
surgery. Second, we did not address non-fatal cardiovas-
cular events during long-term follow-up. Third, we included
both open and endovascular surgical procedures. The
number of endovascular procedures has increased in the
past 3 years, which has influenced the median follow-up
period.
In conclusion, the current study demonstrated that
asymptomatic low ABI has prognostic value to predict per-
ioperative myocardial damage in vascular surgery patients,
incremental to conventional risk factors imbedded in the
RCR and Adapted Lee Risk indices. These data suggest that
ABI measurements should be systematically performed in
patients scheduled for carotid artery stenosis or abdominal
aortic aneurysm repair to ensure that appropriate peri-
operative treatment is initiated.Conflict of Interest
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